The cancer marker neutrophil gelatinase-associated lipocalin is highly expressed in human endometrial hyperplasia. (Q44362116)

2 December 2017

The cancer marker neutrophil gelatinase-associated lipocalin is highly expressed in human endometrial hyperplasia. (English)

1 reference

2 December 2017

Chi-Jr Liao

1

1 reference

2 December 2017

Yen Hua Huang

2

1 reference

2 December 2017

Heng-Kien Au

3

1 reference

2 December 2017

Le-Ming Wang

4

1 reference

2 December 2017

Sin-Tak Chu

5

1 reference

2 December 2017

language of work or name

1 reference

15 May 2011

1 reference

Molecular Biology Reports

2 December 2017

1 reference

2 December 2017

39

1 reference

2 December 2017

2

1 reference

2 December 2017

1029-1036

1 reference

https://scigraph.springernature.com/pub.10.1007/s11033-011-0828-9

2 December 2017

0 references

cites work

The lipocalin protein family: structure and function

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0828-9

Identification of a new acute phase protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0828-9

Uterocalin: a mouse acute phase protein expressed in the uterus around birth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0828-9

Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0828-9

Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0828-9

Neutrophil gelatinase-associated lipocalin acts as a protective factor against H(2)O(2) toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0828-9

Apoptosis induced by uterine 24p3 protein in endometrial carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0828-9

Endometrial leukocytes and menstruation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0828-9

Uterine chemokines in reproductive physiology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0828-9

From endometrial hyperplasia to endometrial cancer: insight into the biology and possible medical preventive measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0828-9

Cyclooxygenase-2 expression in endometrial cancer: correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0828-9

Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0828-9

COX-2 and cancer: a new approach to an old problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0828-9

The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0828-9

Lipocalin 2 promotes breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0828-9

E-cadherin repression contributes to c-Myc-induced epithelial cell transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0828-9

Immunoscreening of urinary bladder cancer cDNA library and identification of potential tumor antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0828-9

The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0828-9

Requirement of lipocalin 2 for chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0828-9

Lipocalin 2 is required for BCR-ABL-induced tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0828-9

beta-catenin mediates glandular formation and dysregulation of beta-catenin induces hyperplasia formation in the murine uterus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0828-9

Mutation of beta-catenin gene in endometrial cancer but not in associated hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0828-9

Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0828-9

Cyclooxygenases in cancer: progress and perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0828-9

Altered expression of beta-catenin, E-cadherin, cycloxygenase-2, and p53 protein by ovine intestinal adenocarcinoma cells

21 January 2018

1 reference

12 December 2020

Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis.

1 reference

12 December 2020

Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer

1 reference

12 December 2020

Cyclooxygenase-2 gene and epithelial ovarian carcinoma risk

1 reference

12 December 2020

Ovarian steroids regulate 24p3 expression in mouse uterus during the natural estrous cycle and the preimplantation period

1 reference

12 December 2020

NGAL decreases E-cadherin-mediated cell-cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells

1 reference

12 December 2020

The relationship between endometrial carcinoma and coexistent adenomyosis uteri, endometriosis externa and myoma uteri

1 reference

12 December 2020

10.1007/S11033-011-0828-9

Identifiers

DOI

1 reference

2 December 2017

1 reference